A Study of GS-0201 in People with Solid Tumors

Full Title

A Phase 1 Study to Evaluate the Safety and Tolerability of GS-0201 as Monotherapy and in Combination in Adults With Advanced Solid Tumors

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Ezra Rosen’s office at 646-888-5109.

Protocol
26-277
Phase
Phase I (phase 1)
Investigator
Ezra Rosen
Co-Investigators
Nicholas Mai
Alison Schram
Diseases
Solid Tumors
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT06167317
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description